A011401-Randomized Phase III Trial Evaluating The Role Of Weight Loss In Adjuvant Treatment Of Overweight And Obese Women With Early Breast Cancer.
Posted Date: May 15, 2019
- Investigator: Neetu Radhakrishnan
- Specialties: Breast Cancer, Cancer, Oncology
- Type of Study: Observational/Survey
To compare the effect of a supervised weight loss intervention plus health education materials versus health education materials alone upon invasive disease free survival (iDFS) in overweight (BMI 27-29.9 kg/m2) and obese (BMI =30kg/m2) women diagnosed with HER-2 negative, stage II and III breast cancer.
To Be Eligible: Patients Must Be 18+ Years Of Age, Patients Must Be Overweight (Bmi > 27) Or Obese Women With Stage 2 Or 3 Breast Cancer, Not Diabetic, No Other Malignancy In Past 4 Years
Breast Cancer, Breast, Cancer, Phase Iii
For More Information:
Uc Cancer Institute